全文获取类型
收费全文 | 821篇 |
免费 | 46篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 48篇 |
妇产科学 | 26篇 |
基础医学 | 52篇 |
口腔科学 | 12篇 |
临床医学 | 95篇 |
内科学 | 174篇 |
皮肤病学 | 19篇 |
神经病学 | 20篇 |
特种医学 | 77篇 |
外科学 | 113篇 |
综合类 | 49篇 |
预防医学 | 68篇 |
眼科学 | 30篇 |
药学 | 50篇 |
中国医学 | 1篇 |
肿瘤学 | 31篇 |
出版年
2022年 | 9篇 |
2020年 | 12篇 |
2019年 | 9篇 |
2018年 | 8篇 |
2017年 | 8篇 |
2016年 | 10篇 |
2015年 | 7篇 |
2014年 | 18篇 |
2013年 | 16篇 |
2012年 | 11篇 |
2011年 | 11篇 |
2010年 | 18篇 |
2009年 | 30篇 |
2008年 | 15篇 |
2007年 | 11篇 |
2006年 | 10篇 |
2003年 | 7篇 |
2002年 | 7篇 |
2001年 | 7篇 |
1999年 | 12篇 |
1998年 | 18篇 |
1997年 | 16篇 |
1996年 | 32篇 |
1995年 | 18篇 |
1994年 | 17篇 |
1993年 | 23篇 |
1992年 | 19篇 |
1991年 | 16篇 |
1990年 | 17篇 |
1989年 | 14篇 |
1988年 | 21篇 |
1987年 | 16篇 |
1986年 | 15篇 |
1985年 | 21篇 |
1984年 | 13篇 |
1983年 | 12篇 |
1982年 | 11篇 |
1981年 | 7篇 |
1980年 | 12篇 |
1979年 | 10篇 |
1977年 | 6篇 |
1960年 | 6篇 |
1959年 | 24篇 |
1958年 | 33篇 |
1957年 | 36篇 |
1956年 | 36篇 |
1955年 | 35篇 |
1954年 | 32篇 |
1949年 | 13篇 |
1948年 | 23篇 |
排序方式: 共有873条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
青蒿琥酯皮肤擦剂在小鼠和兔体内的药代动力学研究 总被引:1,自引:0,他引:1
将青蒿琥酯溶于苯二甲酸二甲酯,加适量氨酮制成皮肤擦剂。给兔脱毛后,皮肤涂抹此擦剂25mg/kg后,血药浓度达峰时间平均为2 h,峰浓度平均为1.80μg/ml。药物在兔体内平均驻留时间为3.54 h,清除半衰期约为2.46 h。给小鼠脱毛皮肤涂抹擦剂6.7,31.3和71.4 mg/kg,血药浓度在给药后0.5~4 h达高峰,峰浓度分别为0.82,2.05和7.11μg/ml,体内药物平均驻留时间为3.39,2.79及3.54 h,清除半衰期为2.35,1.93及2.45 h。可见,给兔及小鼠皮肤擦剂后,青蒿琥酯吸收良好,血药浓度维持时间较长。 相似文献
6.
7.
PHILLIPS ROSALIND; CARSON PETER; HAITES NEVA; JOHNSTON ALAN; CLARKE CYRIL; WHITEFIELD A. G. W. 《QJM : monthly journal of the Association of Physicians》1987,63(2):441-448
A Comparison of mortality from ischaemic heart disease underthe age of 60 for 1980 to 1981 between the Grampian Health Boardand the North Staffordshire Health Authority has been made.A total of 993 deaths was notified by death certificate fromthe two areas of similar population of which 434 were from Grampianand 559 from North Staffordshire. After examination of generalpractitioner and hospital case notes, autopsy reports and deathcertificates, nearly all (532) of the North Staffordshire deathswere accepted as being due to ischaemic heart disease but onlythree-fifths (263) of the Grampian deaths could be begin besubstantiated as there was inadequate information for the remainder.Deaths from ischaemic heart disease seem apparently to be twofoldgreater in North Staffordshire than Grampian but much of thisdiscrepancy could be attributed to a widely different autopsyrate and to unavailability of case notes. Experience of thissurvey suggests that the results of other epidemiological investigationsmay be equally or even more unreliable. 相似文献
8.
The efficacy of tobramycin in the treatment of ulcerative colitis 总被引:11,自引:4,他引:7
D. A. BURKE A. T. R. AXON S. A. CLAYDEN M. F. DIXON D. JOHNSTON R. W. LACEY 《Alimentary pharmacology & therapeutics》1990,4(2):123-129
This paper reports a double-blind placebo-controlled trial of oral tobramycin in acute ulcerative colitis. Eighty-four patients with an acute relapse of ulcerative colitis were randomized to receive oral tobramycin or placebo for 1 week as an adjunct to steroid therapy. At endpoint, 31 of 42 (74%) in the tobramycin group achieved complete symptomatic remission compared with 18 of 42 (43%) in the placebo group (P = 0.008). The tobramycin group achieved better histological scores (P less than 0.05) at endpoint. These findings show that treatment with oral tobramycin improves the short-term outcome of patients with ulcerative colitis in relapse. 相似文献
9.
ANTHONY D. MERCANDO SEYMOUR FURMAN DEBRA JOHNSTON ROSEMARY FRAME RICHARD BRODMAN SOO G. KIM JOHN D. FISHER 《Pacing and clinical electrophysiology : PACE》1988,11(11):2059-2063
Between May 1982 and May 1988, 37 patients (28 males and 9 females, mean age 57.6, range 16–76 years) of approximately 600 evaluated for sustained ventricular tachycardia and/or fibrillation (VT/VF) were treated with an automatic implantable cardioverter defibrillator (AICD). Twenty-eight of the patients had coronary artery disease, 7 had nonischemic cardiomyopathy, 1 had amyloid hear disease, and 1 had rheumatic heart disease. The mean ejection fraction was 32.2 ± 12.9% (range, 9–64%). Eleven patients have died at a mean of 16.7 months after implantation. The cumulative survival rate was 81% at 1 year, 77% at 2 years. 68% at 3 years, and 53% at 4, 5, and 6 years. Considering only sudden deaths, the survival was 97% at 1 and 2 years, 90% at 3 years, and 80% at 4, 5, and 6 years. Twenty-one of the 37 patients received spontaneous shocks. If the first shock marks the time to death in the absence of an AICD, the cumulative survival rate would have been 56% at 1 year, 42% at 2 years, 29% at 3 years, and 14% at 4, 5, and 6 years. The maximum amount of time to a first appropriate shock was 39.7 months. Thirty-nine devices have been explanted; 28 for battery depletion; 5 for infections; 3 for improper sensing; 2 for electronic failure; and 1 at the time of cardiac transplantation. The average time to failure of the 28 units removed for battery depletion was 19.8 ±6.9 months. We conclude that in this group of patients, short-term survival is increased by AICD implantation, hut long-term survival remains poor. Incidence of sudden death is reduced to 3% at 1 and 2 years, 10% at 3 years, and 20% after 4 years. Other patient selection criteria may be useful in selecting those patients whose survival will be improved by the AICD. 相似文献
10.